期刊文献+

Summary of 32 Patients with Cardiac Syndrome X Treated by TCM Therapy of Regulating Qi Relieving Chest Stuffiness and Promoting Blood Circulation 被引量:8

Summary of 32 Patients with Cardiac Syndrome X Treated by TCM Therapy of Regulating Qi Relieving Chest Stuffiness and Promoting Blood Circulation
原文传递
导出
摘要 Objective: To evaluate the clinical effect of Liqi Kuanxiong Huoxue method (宽胸活血,LKH, traditional Chinese medicine, TCM therapeutic method for regulating qi, relieving chest stuffiness and promoting blood circulation) in treating patients with cardiac syndrome X (CSX). Methods: The prospective, non-randomized controlled study was conducted on 51 selected patients with CSX, who were non-randomly assigned to 2 groups, the treated group treated with LKH in addition to the conventional treatment (32 patients), and the control group treated with conventional treatment (19 patients) like nitrate, diltiazem hydrochloride, etc. The treatment course was 14 days. The changes of such symptoms as angina pectoris, TCM syndrome and indexes of treadmill exercise test before and after treatment were observed. Results: After treatment, such symptoms as chest pain and stuffy feeling and palpitation in the treated group were improved more than those in the control group (P〈0.05); the total effective rate on angina pectoris and TCM syndrome in the treated group was better than that in the control group (P〈0.05). The treadmill exercise test showed that the maximal metabolic equivalent (Max MET), the time of angina onset and ST segment depression by 0.1 mV were obviously improved after treatment in both groups, but the improvement in the treated group was better than that in the control group respectively (P〈0.05). Conclusion: The LKH method could reduce the frequency of angina attacks and improve the clinical condition of patients with CSX. Objective: To evaluate the clinical effect of Liqi Kuanxiong Huoxue method (宽胸活血,LKH, traditional Chinese medicine, TCM therapeutic method for regulating qi, relieving chest stuffiness and promoting blood circulation) in treating patients with cardiac syndrome X (CSX). Methods: The prospective, non-randomized controlled study was conducted on 51 selected patients with CSX, who were non-randomly assigned to 2 groups, the treated group treated with LKH in addition to the conventional treatment (32 patients), and the control group treated with conventional treatment (19 patients) like nitrate, diltiazem hydrochloride, etc. The treatment course was 14 days. The changes of such symptoms as angina pectoris, TCM syndrome and indexes of treadmill exercise test before and after treatment were observed. Results: After treatment, such symptoms as chest pain and stuffy feeling and palpitation in the treated group were improved more than those in the control group (P〈0.05); the total effective rate on angina pectoris and TCM syndrome in the treated group was better than that in the control group (P〈0.05). The treadmill exercise test showed that the maximal metabolic equivalent (Max MET), the time of angina onset and ST segment depression by 0.1 mV were obviously improved after treatment in both groups, but the improvement in the treated group was better than that in the control group respectively (P〈0.05). Conclusion: The LKH method could reduce the frequency of angina attacks and improve the clinical condition of patients with CSX.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第1期17-21,共5页 中国结合医学杂志(英文版)
基金 Priority Project of Tianjin Science Technical Commission (No. 05YFGDSF02200) Yan De-xin Foundation Project (No. 05-012)
关键词 cardiac syndrome X qi stagnation phlegm obstruction and blood stasis regulating qi relieving chest stuffiness and promoting blood circulation method cardiac syndrome X, qi stagnation, phlegm obstruction and blood stasis, regulating qi, relieving chest stuffiness and promoting blood circulation method
  • 相关文献

参考文献13

  • 1[1]Cannon R,Leon MB,Watson RM,et al.Chest pain and "normal" coronary arteries-role of small coronary arteries.Am J Cardiol 1985;55:50B.
  • 2[2]Ali O,Smart FW,Nguyen T,et al.Recent development in microvascular angina.Curr Atheroscler Rep 2001;3:149.
  • 3[3]Masumoto A.Mohri M.Takeshita A.Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm.Int J Cardiol 2001;81:151.
  • 4[4]Mao JY,Zhang ZP,Wang HH,et al.Clinical analysis of 12 patients with cardiac syndrome X.Emerg Tradit Chin Med 2005;14(4):368-369.
  • 5[5]Kaski JC.Valenzuela Ganrcia LF.Therapeutic options for the management of patients with cardiac syndrome X.Eur Heart J 2001;22:283-293.
  • 6[6]Zheng XY.Guiding Principle of clinical research on new drugs of TCM.1st ed.Beijing:China Medicine Pharmaceutical Science and Technology Publishing House,2002:68-73.
  • 7[7]Wang YY,editor.Internal medicine of traditional Chinese medicine.6th ed.Shanghai:Shanghai Science and Technology Publlshing House,1999:108-114.
  • 8[8]Goel PK,Gupta SK,Agarwal A,et al.Slow coronary flow:a distinct angiographic subgroup in syndrome X.Angiology 2001;52:507-514.
  • 9[9]Miatello R,Risler N,Castro C,er al.Aortic smooth muscle cell Proliferation and endothelial nitric oxide svnthase activitve in fructose-fed rats.Am J Hypertens 2001;14:1135.
  • 10[10]Peters NS.Milson I.Beneficial effect of treatment with transdermal estradiol-17 β on exercise-induced angina and ST segment depression in Syndrome X.Int J Cardiol 2000;64:13-20.

同被引文献53

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部